SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Democratic gains in the midterms have fueled concern that tighter AI rules and data-center permitting delays could slow the buildout supporting Nvidias sales, weighing on the stock alongside broader semiconductor weakness. Traders disagree on whether the policy fears and doubts about AI spending are real threats or overblown, with some buying the dip on expectations that demand will persist.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a semiconductor selloff as traders worry Democratic election gains could bring tighter oversight or slower permitting for AI data centers, threatening the buildout that supports memory demand. The community is split between those who see the AI trade and memory pricing outlook weakening and bulls who view the decline as an overreaction, arguing that AI demand and data-center construction will persist.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms quarterly results sparked debate: a modest earnings beat and stronger revenue outlook were offset by a softer EPS outlook, sharply weaker handset sales, and rising component costs. Traders are weighing whether growth in automotive, data center and other non-handset businesses can offset pressure on the phone-chip business.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arms quarterly results beat expectations, but shares sold off as traders focused on modest forward guidance and slower royalty growth despite strong licensing and data-center demand. The reaction reflects concern that strong results may not justify the stocks valuation amid weakness across AI and semiconductor shares, while some traders view the pullback as a buying opportunity.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastlys quarterly results beat estimates and management raised its full-year outlook, but shares sold off sharply after the report. Traders are debating whether the decline reflects expectations that were even higher, with bullish posters pointing to improving margins and cash flow while others focus on the weak price reaction and volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisks selloff is drawing attention amid concerns that Democratic gains in Congress could bring tighter AI and data-center rules, slowing infrastructure buildouts and demand for memory chips. Traders are split between seeing the policy fears and broader chip-sector weakness as an overreaction, with memory demand intact, and fearing a longer AI-investment or memory-cycle downturn.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXLs steep decline is being tied to broad semiconductor selling and trader concerns that the Democratic midterm sweep could bring tighter scrutiny or delays for AI data centers, weighing on chip demand. The community is split between bearish claims that the AI trade is ending and dip buyers who view the selloff as an overreaction; SOXLs 3x leverage magnifies the swings.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is drawing attention after traders highlighted a reported quarterly beat and raised revenue guidance, alongside progress in its oncology pipeline. Reactions remain mixed: some see the update as evidence of improving momentum, while others remain cautious about clinical setbacks and leadership changes.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers quarterly results topped expectations, with strong bookings growth and cash generation, but a softer-than-hoped outlook and concerns about driver supply and mobility revenue tempered the reaction. Traders are split between seeing improving core profitability and long-term robotaxi potential, and worrying that competition and the stocks fading gains point to further weakness.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA filing for sonelokimab in hidradenitis suppurativa has put the FDAs review-acceptance and review-timeline decisions in focus. Traders are divided: bulls see the filing and clinical data as important progress, while bears worry about regulatory risk, a go-it-alone commercial strategy, and potential future dilution amid the share-price decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Skin-Care Biotech Jumps 88% as Lab Data Shows 50% Wrinkle Reduction

Delivering rapid, quantifiable anti-aging results in ex vivo human skin models triggered a dramatic surge in small-cap dermatology today, illustrating how robust preliminary tissue data can de-risk upcoming clinical work.&nbsp;Azitra Inc. (NYSE American: AZTR), a Connecticut clinical-stage dermatology biotech, surged Monday after releasing positive ex vivo study results for its cosmetic candidate ATR-COSF. The hydrogel formulation incorporates growth liquid from engineered S. epidermidis bacteria to deliver a functional unit of the human protein filaggrin. In tested human skin tissue, a ...

Companies Pushing Experimental Treatments Toward Their Biggest Tests

These biotechnology companies are advancing important developments. NeOnc Technologies Holdings (NASDAQ:NTHI) is outlining plans for a major international brain cancer trial, Azitra (NYSEAMERICAN:AZTR) is preparing human testing of its experimental anti-wrinkle technology, ArriVent BioPharma (NASDAQ:AVBP) is reporting encouraging early response data for its gastrointestinal cancer candidate, Xencor (NASDAQ:XNCR) is advancing its experimental kidney cancer therapy toward a potential registration-enabling study, and SciSparc (NASDAQ:SPRC) is moving closer to patient enrollment in its Phase IIb Tourette syndrome trial.

AI, Biotech, And Healthcare Catalysts Drive Momentum

Several emerging public companies are attracting attention as artificial intelligence, healthcare innovation, medical technology, and international commercialization strategies continue converging across the market. From AI-powered drug discovery and regenerative medicine expansion to precision dermatology and medical device innovation, recent developments highlight how smaller companies are positioning themselves around some of the fastest-growing sectors in healthcare and technology. $TGNT, $NXTS, $AZTR, $ADTX, $TNON, $PFE

Technological Innovations to Wage War Against Some of Medicine's Toughest Diseases

The biotechnology space is delivering a steady stream of potentially market-moving developments this week as companies across oncology, neuroscience, gene therapy, medical devices, and synthetic biology delivered significant regulatory, clinical, and commercial updates. $NTHI, $QURE, $ICCM, $CLPT, $ELTX, $AZTR

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for...

This Nano-Cap Pharma Stock Surged 80% Days After A Listing Warning — What’s Fueling the Rally?

Equity

The stock crossed its 100-DMA for the first time in more than eight months after announcing a private placement to raise over $31 million.

Small Caps Swing Big: Capital Raises Fuel AI, Biotech, and EV Ambitions

A flurry of financings, strategic pivots, and technology-driven initiatives is energizing the small-cap space, as companies tap capital markets to chase growth across AI, biotech, and next-generation transportation. $TGNT, $AZTR, $WNW, $UCAR, $JDZG

Nasdaq, S&P 500 Futures Take A Breather Ahead Of Massive Options Expiry: Why SMCI, NVDA, TSLA, UAMY, IBRX Are Keeping Traders Engaged Today

Data from Stocktwits indicated that retail sentiment remains bearish on SPY and QQQ. 


Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million Azitra Announces Pricing of Private Placement...

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.

Azitra Inc

Neutral Sentiment

<ul class="summary-bullets"><li>The funding includes a $10.5 million upfront offering and up to $20.9 million from warrant exercises.</li><li>The company plans to use the proceeds to advance new protein and peptide research programs.</li><li>Last week, Azitra received a notice from the NYSE for failing to meet its minimum stockholders’ equity requirement of $6 million.</li></ul>Shares of Azitra Inc. (AZTR) surged more than 80% on Friday, crossing over its 100-day moving average for the first time since June 2025, after the biopharmaceutical firm announced a private placement to raise over $31 million.<figure class="image"><a class="st-link-external" href="https://in.tradingview.com/chart/teA7VKVN/?symbol=AMEX%3AAZTR" target="_blank" rel="noopener noreferrer nofollow"><img src="https://news.stocktwits-cdn.com/aztr_jpg_0fe58a1f37.webp" alt="aztr.jpg" width="1345" height="849"></a></figure>Source: TradingViewOn Friday, <a href="https://stocktwits.com/symbol/AZTR">AZTR shares</a> recorded their biggest intraday gains since July 27, 2024.<h2 class="st-heading-2">Azitra To Advance New Protein And Peptide Research Programs</h2>Azitra said it is in the process of securing a financing deal worth up to $31.4 million to support its expansion into the cosmetic and cosmeceutical markets. The funding includes an initial $10.5 million offering through convertible preferred stock, with an additional $20.9 million tied to the potential exercise of warrants.The transaction is backed by institutional healthcare investors, including Stonepine Capital and Nantahala Capital.The company plans to use the proceeds to advance new protein and peptide research programs, using its microbial genetic engineering platform. Azitra aims to accelerate the development and commercialization of skincare solutions targeting issues such as dry skin and ageing.“We are confident these technologies offer an exciting new way to address the appearance of fine lines and wrinkles as well as dry, sensitive skin and eczema-like rashes,” said CFO Francisco Salva.<h2 class="st-heading-2">Azitra’s Listing Challenges</h2>Last week, Azitra received a notice from NYSE American LLC for failing to meet its minimum stockholders’ equity requirement of $6 million for companies with recent losses. The company has until April 1, 2027, to regain compliance, during which it will remain listed but will be subjected to regular reviews of its progress.According to Azitra’s latest financial update for the full-year ended Dec. 31, 2025, net loss widened to $11 million from $9 million a year earlier.The company also said it expects to report the topline Phase 1b results for its lead candidate, ATR12-351, for the treatment of Netherton, a rare and severe genetic skin disorder, in the second half of 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday surge, retail sentiment has remained in the ‘bearish’ zone over the past 24 hours.One user said the stock could climb over $1 on the daily chart if the volume holds.<stembedurl>https://stocktwits.com/TonyStacks/message/648079663</stembedurl>Nearly 230 million shares changed hands in the first 20 minutes of trading, compared with an average of 1.8 million, according to Stocktwits data.Year-to-date, the stock has gained around 23%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/apple-aapl-stock-downtrend-200dma-retail-concern/cZ3XqspRILL">AAPL Stock’s Decline Leads It Toward 200-DMA For First Time In Over 7 Months – Retail Concerned Over Lack Of Catalysts</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Current Price	$0.8157
Prev Close	$0.8838
Open	$0.8569
Dividend Yield	0.00%
50-Day Moving Average	$1.34
Beta	1.39
Avg. Volume	7.35M
PE Ratio	-0.06

52-Week High	$4.56
52-Week Low	$0.518
Market Capitalization	$5.36M
EPS (Annual)	-$22.48
Price to Book	0.67
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

AZTR Fundamentals